FDA Investigator Timothy M Glod
Timothy M Glod has conducted inspections on 103 sites in 1 countries as of 08 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
103
Last Inspection Date:
08 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Timothy M Glod:
Alan R Condon,
Aldo J Quintana,
Alfred P Pistorio,
Alice C Silva,
Alysia M Salonia,
Amber G Wardwell,
Ann L Simoneau,
Anne E Carpenter,
Anthony P Costello,
Anthony W Thomas,
Atricia L Irons,
Barbara L Williams,
Bradley D Newsad,
Brenda P King,
Brenna L Macdowell,
Carla C Tuite,
Christine L Williams,
Christopher A Demitrius,
Christopher K Vantwuyver,
Christopher M Elliott,
Courtney N Long,
Darin S Wiegers,
Daryl A Dewoskin,
Donahue,
Dorothy W Lee,
Douglas S Joslin,
Eduardo L Rodriguez,
Elizabeth B Griffin,
Frank J Mazzoni,
Garry H Stewart,
Gerard D Difiore,
Hien Albright,
Jaime E Pares,
Jamie S Mathews,
Jason D Tenney,
Jay M Patria,
Jeffery A Hangartner,
Jeffrey S Buckser,
Jessica I Newman,
John A Hollings,
John L Zaccone,
John P Shelton,
Jonathan G Matrisciano,
Joppie,
Joseph B Cascio,
Joseph Foley,
Joseph H Procopio, Jr,
Joshua L Gibbs,
Joyce A Kellett,
Joyce A Williams,
Julie A Finegan,
Kathleen A Sousa,
Kathleen E Mcafoose,
Kathleen M Curry,
Kent A Conforti,
Kimberly J Langello,
Lauren M Lawrance,
Laurie B Frazier,
LCDR Debra Emerson,
Liz M Otero,
Lorayne A Mcguinness,
Margaret E Walsh,
Mark E Farrell,
Martin J Guardia,
Maryam Tabatabaie,
Megan A Haggerty,
Michael E Antaya,
Michelle M Noe Varga,
Monique C Lo,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Ramon E Martinez,
Raymond M Lam,
Rebecca A Coleman,
Rebecca B Welch,
Richard F Hapke,
Richard H Penta,
Richard L Licari,
Robert E Teel,
Robert J Martin,
Robert O'brian,
Rupa Pradhan,
Sandra P White,
Sean M Tessicini,
Shawn M Bogdan,
Slater K Bartlett,
Stephen C King,
Teddy Tom,
Thomas Cote,
Thomas J Kelly,
Thomas J Murphy,
Thomas Siebertz,
Thomas W Nerney,
Troy R Petrillo,
Victoria Taylor,
Wendy A Johnecheck,
William K Dagley
Timothy M Glod's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2003 | FDA 483 | Biomat USA Inc. - Form 483, 2003-05-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more